SRDX - SurModics - Biotech IPO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SRDX - SurModics - Biotech IPO

SRDX 31.15

+5.7%

Apr 28 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Lance Bredvold	3/11/2025 10:28:41 AM
	of 83

The FTC is challenging the acquisition of SRDX by GTCR because the latter owns BIOCOAT, the second largest designer of hydrophilic coatings. SRDX says they'll fight in court which means they not only wasted time and money on the sale, but now will spend more on arguing about it. Not sure whether that might be worthwhile, but I wish I'd known about the competitor long ago. Perhaps I've lost a bit of trust in management but still have an outsized position. Fortunately escaped some high priced shares profitably (around $39). It now appears the stock price is primarily dependent upon how quickly the various stents can become profitable. Or perhaps an offer of the company to a second bidder for a lower price.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next